Trial · NCT05028582
Results by group40
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 40
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Achievement of Scalp Investigator Global Assessment (S-IGA) Success at Week 8 | Roflumilast Foam 0.3% | 66.4 | 97.5% Confidence Interval 59.62 to 72.56 | percentage of participants | |
| Achievement of Scalp Investigator Global Assessment (S-IGA) Success at Week 8 | Vehicle Foam | 27.8 | 97.5% Confidence Interval 20.12 to 37.10 | percentage of participants | |
| Achievement of Body Investigator Global Assessment (B-IGA) Success at Week 8 | Roflumilast Foam 0.3% | 45.5 | 97.5% Confidence Interval 38.87 to 52.33 | percentage of participants | |
| Achievement of Body Investigator Global Assessment (B-IGA) Success at Week 8 | Vehicle Foam | 20.1 | 97.5% Confidence Interval 13.55 to 28.81 | percentage of participants | |
| Achievement of Scalp Itch-Numeric Rating Score (SI-NRS ) Success at Week 2 | Roflumilast Foam 0.3% | 25.2 | 97.5% Confidence Interval 18.96 to 32.63 | percentage of participants | |
| Achievement of Scalp Itch-Numeric Rating Score (SI-NRS ) Success at Week 2 | Vehicle Foam | 8.0 | 97.5% Confidence Interval 3.90 to 15.55 | percentage of participants | |
| Achievement of SI-NRS Success at Week 4 | Roflumilast Foam 0.3% | 46.2 | 97.5% Confidence Interval 38.32 to 54.22 | percentage of participants | |
| Achievement of SI-NRS Success at Week 4 | Vehicle Foam | 16.8 | 97.5% Confidence Interval 10.40 to 26.04 | percentage of participants | |
| Achievement of SI-NRS Success at Week 8 | Roflumilast Foam 0.3% | 65.3 | 97.5% Confidence Interval 57.26 to 72.58 | percentage of participants | |
| Achievement of SI-NRS Success at Week 8 | Vehicle Foam | 30.3 | 97.5% Confidence Interval 21.38 to 40.91 | percentage of participants | |
| Change From Baseline in SI-NRS Score at Day 1 | Roflumilast Foam 0.3% | -0.44 | Standard Error 0.120 | score on a scale | |
| Change From Baseline in SI-NRS Score at Day 1 | Vehicle Foam | -0.09 | Standard Error 0.149 | score on a scale | |
| Change From Baseline in SI-NRS Score at Day 3 | Roflumilast Foam 0.3% | -1.11 | Standard Error 0.133 | score on a scale | |
| Change From Baseline in SI-NRS Score at Day 3 | Vehicle Foam | -0.36 | Standard Error 0.165 | score on a scale | |
| Change From Baseline in SI-NRS Score at Week 1 | Roflumilast Foam 0.3% | -1.08 | Standard Error 0.121 | score on a scale | |
| Change From Baseline in SI-NRS Score at Week 1 | Vehicle Foam | -0.53 | Standard Error 0.151 | score on a scale | |
| Achievement of WI-NRS (Worst Itch-Numeric Rating Score) Success at Week 8 | Roflumilast Foam 0.3% | 63.1 | 97.5% Confidence Interval 54.97 to 70.59 | percentage of participants | |
| Achievement of WI-NRS (Worst Itch-Numeric Rating Score) Success at Week 8 | Vehicle Foam | 30.1 | 97.5% Confidence Interval 20.69 to 41.44 | percentage of participants | |
| Achievement of a 75% Reduction From Baseline in Psoriasis Area and Severity Index (PASI-75) | Roflumilast Foam 0.3% | 50.1 | 97.5% Confidence Interval 43.24 to 56.91 | percentage of participants | |
| Achievement of a 75% Reduction From Baseline in Psoriasis Area and Severity Index (PASI-75) | Vehicle Foam | 16.8 | 97.5% Confidence Interval 10.77 to 25.15 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05028582/results